Is Thyroid Dysfunction Associated with Unruptured Intracranial Aneurysms? A Population-Based, Nested Case–Control Study from Korea
Abstract
Background: Few risk factors for the development of intracranial aneurysms (IAs) are known. We investigated the potential role of thyroid diseases in IA development using nationwide real-world data.
Methods: A nested case–control study within the National Health Insurance Service—National Sample Cohort data from 2002 to 2019 was performed. A total of 5335 patients with unruptured IA were matched by age and sex with 80,025 controls at a ratio of 1:15. We estimated the odds ratios (ORs) and corresponding confidence intervals [CIs] between thyroid diseases and unruptured IA using a multivariable conditional logistic regression model.
Results: Tobacco smoking, use of antihypertensive medication, and hypothyroidism were significantly associated with an elevated risk for unruptured IA in univariate analysis. In multivariable analysis, a history of hypothyroidism was associated with unruptured IA (adjusted OR: 1.46 [CI: 1.26–1.69]). Among patients with hypothyroidism, long-term use of thyroid hormone for >5 years was associated with a reduced risk for unruptured IA (adjusted OR: 0.69 [CI: 0.48–0.99]). A history of hyperthyroidism was associated with a reduced risk for unruptured IAs (adjusted OR: 0.71 [CI: 0.54–0.93]). In secondary analyses of the data according to sex, the respective observed associations between hypothyroidism and hyperthyroidism and the risk of IAs were found to be statistically significant in females but not in males.
Conclusions: Hypothyroidism is associated with an increased risk of unruptured IAs, whereas hyperthyroidism is associated with a reduced risk. Overall, the findings suggest that thyroid hormones may play a protective role in the development of unruptured IAs. Further studies are needed to clarify potential direct causality and the biologic mechanisms relating thyroid dysfunction and unruptured IA.
Get full access to this article
View all available purchase options and get full access to this article.
References
1. Vlak MH, Algra A, Brandenburg R, et al. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 2011;10(7):626–636;
2. Cho W-S, Lee SH, Kang H-S, et al. Management of incidentally found unruptured intracranial aneurysms. J Korean Med Assoc 2020;63(5):267–274;
3. Cho WS, Kim JE, Park SQ, et al. Korean Clinical Practice Guidelines for aneurysmal subarachnoid hemorrhage. J Korean Neurosurg Soc 2018;61(2):127–166;
4. Kim T, Lee H, Ahn S, et al. Incidence and risk factors of intracranial aneurysm: a national cohort study in Korea. Int J Stroke 2016;11(8):917–927;
5. Thompson BG, Brown RD Jr., Amin-Hanjani S, et al. Guidelines for the management of patients with unruptured intracranial aneurysms: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015;46(8):2368–2400;
6. Jeong HW, Seo JH, Kim ST, et al. Clinical practice guideline for the management of intracranial aneurysms. Neurointervention 2014;9(2):63–71;
7. Hee SD, Seung KH, Won KD, et al. Guidelines for the management of unruptured intracranial aneurysm. Korean J Cerebrovasc Surg 2011;13(4):279–290.
8. Ronkainen A, Hernesniemi J, Puranen M, et al. Familial intracranial aneurysms. Lancet 1997;349(9049):380–384;.
9. Pirson Y, Chauveau D, Torres V. Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2002;13(1):269–276;.
10. Yoo WS, Chung HK. Subclinical hypothyroidism: prevalence, health impact, and treatment landscape. Endocrinol Metab (Seoul) 2021;36(3):500–513;
11. Papaioannou GI, Lagasse M, Mather JF, et al. Treating hypothyroidism improves endothelial function. Metab Clin Exp 2004;53(3):278–279;
12. Taddei S, Caraccio N, Virdis A, et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 2003;88(8):3731–3737;
13. Sohn SY, Lee E, Lee MK, et al. The association of overt and subclinical hyperthyroidism with the risk of cardiovascular events and cardiovascular mortality: meta-analysis and systematic review of cohort studies. Endocrinol Metab (Seoul) 2020;35(4):786–800;
14. Bano A, Chaker L, Mattace-Raso FUS, et al. Thyroid function and the risk of atherosclerotic cardiovascular morbidity and mortality: The Rotterdam Study. Circ Res 2017;121(12):1392–1400;
15. Yang MH, Yang FY, Lee DD. Thyroid disease as a risk factor for cerebrovascular disease. J Stroke Cerebrovasc Dis 2015;24(5):912–920;
16. Atchaneeyasakul K, Tipirneni A, Zhang T, et al. Association of hypothyroidism with unruptured cerebral aneurysms: a case-control study. J Neurosurg 2018;128(2):511–514;
17. Chien A, Callender RA, Yokota H, et al. Unruptured intracranial aneurysm growth trajectory: occurrence and rate of enlargement in 520 longitudinally followed cases. J Neurosurg 2019;132(4):1077–1087;
18. Cheol Seong S, Kim YY, Khang YH, et al. Data resource profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol 2017;46(3):799–800;
19. Lee J, Lee JS, Park SH, et al. Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol 2017;46(2):e15;
20. Lee SU, Kim T, Kwon OK, et al. Trends in the incidence and treatment of cerebrovascular diseases in Korea: Part I. Intracranial aneurysm, intracerebral hemorrhage, and arteriovenous malformation. J Korean Neurosurg Soc 2020;63(1):56–68;
21. Cho SW, Kim JH, Choi HS, et al. Big data research in the field of endocrine diseases using the Korean National Health Information Database. Endocrinol Metab (Seoul) 2023;38(1):10–24;
22. Nakamura H, Noh JY, Itoh K, et al. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab 2007;92(6):2157–2162;
23. Peterson AM, Nau DP, Cramer JA, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007;10(1):3–12;
24. SAS Institute Inc. SAS software, Version 9.4. 2016. Available from: https://sas.com [Last accessed: August 10, 2023].
25. Ahn HY, Cho SW, Lee MY, et al. Prevalence, treatment status, and comorbidities of hyperthyroidism in Korea from 2003 to 2018: A nationwide population study. Endocrinol Metab (Seoul) 2023;
26. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87(2):489–499;
27. McGrogan A, Seaman HE, Wright JW, et al. The incidence of autoimmune thyroid disease: a systematic review of the literature. Clin Endocrinol (Oxf) 2008;69(5):687–696;
28. Kim DH S-ST, Qualmann KJ, O'Leary JSB, et al. Pathobiology of Intracranial Aneurysms. In: Youmans and Winn Neurological Surgery. (Winn HR. eds.) Elsevier: Philadelphia; 2022.
29. Izkhakov E, Meyerovitch J, Barchana M, et al. Long-term cardiovascular and cerebrovascular morbidity in Israeli thyroid cancer survivors. Endocr Connect 2019;8(4):398–406.
30. Suh B, Shin DW, Park Y, et al. Increased cardiovascular risk in thyroid cancer patients taking levothyroxine: a nationwide cohort study in Korea. Eur J Endocrinol 2019;180(1):11–20.
31. Smallridge RC, Rogers J, Verma PS. Serum angiotensin-converting enzyme. Alterations in hyperthyroidism, hypothyroidism, and subacute thyroiditis. JAMA 1983;250(18):2489–2493;
32. Lee DS, Chung JK, Cho BY, et al. Changes of serum angiotensin-converting enzyme activity during treatment of patients with Graves' disease. Korean J Intern Med 1986;1(1):104–112;
33. Ojamaa K, Klemperer JD, Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 1996;6(5):505–512;
34. Hiroi Y, Kim HH, Ying H, et al. Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci U S A 2006;103(38):14104–14109;
35. Cai Y, Manio MM, Leung GP, et al. Thyroid hormone affects both endothelial and vascular smooth muscle cells in rat arteries. Eur J Pharmacol 2015;747:18–28;
36. Kim S, Kim MS, You SH, et al. Conducting and reporting a clinical research using Korean Healthcare Claims Database. Korean J Fam Med 2020;41(3):146–152;
Information & Authors
Information
Published In
Copyright
Copyright 2023, Mary Ann Liebert, Inc., publishers.
History
Published online: 7 December 2023
Published in print: December 2023
Published ahead of print: 15 November 2023
Published ahead of production: 16 October 2023
Authors
Authors' Contributions
H.P.: Conceptualization (equal); formal analysis (lead); writing—original draft (equal); writing—review and editing (equal); S.W.C.: Conceptualization (equal); writing—original draft (equal); writing—review and editing (equal); S.H.L.: Writing—review and editing (equal); K.K.: Writing—review and editing (equal); H.-S.K.: Writing—review and editing (equal); J.E.K.: Writing—review and editing (equal); A.S.: Conceptualization (equal); formal analysis (supporting); writing—original draft (equal); writing—review and editing (equal); W.-S.C.: Conceptualization (equal); writing—original draft (equal); writing—review and editing (equal).
Author Disclosure Statement
No competing financial interests exist.
Funding Information
W.-S.C.: Seoul National University Hospital Research Fund (Grant No.: 0420203080).
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.